Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

SZSE Ticker: 300110

Huaren Pharmaceutical Co., Ltd.

华仁药业股份有限公司

华仁药业

HRYY

Listing Date: 2010-08-25

Board: GEM

Industry Classification: Manufacturing

The latest announcement of Huaren Pharmaceutical: Wholly-owned subsidiary pentazocine API has been approved by CDE_Stock News_Market Gold Online

  • Post date May 16, 2022 — 23:15 Post Lock Login to View

Read More

Huaren Pharmaceutical: Doxofylline Injection produced by subsidiary Anhui Hengxing Pharmaceutical won the bid for the fourth batch of national centralized procurement_ Oriental Fortune Net

  • Post date May 14, 2022 — 12:23 Post Lock Login to View

Read More

Huaren Pharmaceutical: Doxofylline Injection produced by subsidiary Anhui Hengxing Pharmaceutical won the bid for the fourth batch of national centralized procurement

  • Post date May 14, 2022 — 12:23 Post Lock Login to View

Read More

Which listed company has the best salary? The highest salary of executives exceeds 10 million yuan, and the average salary of employees exceeds 200,000 yuan

  • Post date May 12, 2022 — 20:15 Post Lock Login to View

Read More

5 shares were significantly increased by important shareholders (with shares) Securities Journal

  • Post date May 9, 2022 — 10:50 Post Lock Login to View

Read More

5 shares were significantly increased by important shareholders (with shares) _ Oriental Fortune Net

  • Post date May 9, 2022 — 10:16 Post Lock Login to View

Read More

A number of companies have increased their holdings generously on Saturday, and the actual controller issued a bottom-line commitment

  • Post date April 28, 2022 — 05:37 Post Lock Login to View

Read More

Huaren Pharmaceutical: At present, Mingjitang Cosmetics has been recognized by consumers on the e-commerce platform

  • Post date April 21, 2022 — 21:29 Post Lock Login to View

Read More

  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.